| Intercellular mitochondrial transfer in the tumor microenvironment H Sahinbegovic, T Jelinek, M Hrdinka, JR Bago, M Turi, T Sevcikova, ... Cancers 12 (7), 1787, 2020 | 34 | 2020 |
| The deubiquitinase OTUD1 regulates immunoglobulin production and proteasome inhibitor sensitivity in multiple myeloma A Vdovin, T Jelinek, D Zihala, T Sevcikova, M Durech, H Sahinbegovic, ... Nature Communications 13 (1), 6820, 2022 | 11 | 2022 |
| Tuning CARs: recent advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and flexibility P Celichowski, M Turi, S Charvátová, D Radhakrishnan, N Feizi, Z Chyra, ... Journal of Translational Medicine 21 (1), 197, 2023 | 9 | 2023 |
| Transcriptome analysis of diffuse large b-cell lymphoma cells inducibly expressing MyD88 L265P mutation identifies upregulated CD44, LGALS3, NFKBIZ, and BATF as downstream … M Turi, A Anilkumar Sithara, L Hofmanová, D Žihala, D Radhakrishnan, ... International Journal of Molecular Sciences 24 (6), 5623, 2023 | 7 | 2023 |
| Promises and challenges of immunogenic chemotherapy in multiple myeloma M Johnstone, D Vinaixa, M Turi, E Morelli, KC Anderson, A Gulla Cells 11 (16), 2519, 2022 | 3 | 2022 |
| Loss of GABARAP mediates resistance to immunogenic chemotherapy in multiple myeloma E Morelli, M Johnstone, M Turi, MK Samur, C Botta, S Cifric, P Folino, ... Blood, 2024 | 1 | 2024 |
| DAMPening Tumor Immune Escape: The Role of Endoplasmic Reticulum Chaperones in Immunogenic Chemotherapy S Cifric, M Turi, P Folino, C Clericuzio, F Barello, T Maciel, KC Anderson, ... Antioxidants & Redox Signaling, 2024 | | 2024 |
| Abstract P24: GABARAP deficiency drives resistance to immunogenic chemotherapy in multiple myeloma M Turi, E Morelli, M Johnstone, MK Samur, C Botta, S Cifric, P Folino, ... Blood Cancer Discovery 5 (2_Supplement), P24-P24, 2024 | | 2024 |
| Abstract P37: Decoding Cancer Dependency and Molecular Pathways of Long Noncoding RNAs with a Novel CRISPR-Cas13d Platform E Morelli, A Aktas-Samur, D Maisano, C Gao, N Liu, V Favasuli, M Turi, ... Blood Cancer Discovery 5 (2_Supplement), P37-P37, 2024 | | 2024 |
| CRISPR-Based Functional Transcriptomics Defines the Tumor-Dependency and Molecular Determinants of Long Noncoding RNAs in Multiple Myeloma E Morelli, A Aktas-Samur, D Maisano, C Gao, N Liu, V Favasuli, M Turi, ... Blood 142, 640, 2023 | | 2023 |
| P-195 Loss of GABARAP mediates resistance to immunogenic chemotherapy by altering protein trafficking of calreticulin on the cell surface A Gulla, E Morelli, M Johnstone, M Turi, M Samur, C Botta, S Cifric, ... Clinical Lymphoma Myeloma and Leukemia 23, S143, 2023 | | 2023 |
| PB2397: TRANSCRIPTOME ANALYSIS OF DIFFUSE LARGE B-CELL LYMPHOMA CELLS EXPRESSING MYD88 L265P REVEALS CD44, LGALS3, NFKBIZ AND BATF AS DOWNSTREAM TARGETS OF ONCOGENIC NF-ΚB … M Turi, AA Sithara, L Hofmanová, D Žihala, D Radhakrishnan, A Vdovin, ... HemaSphere 7 (S3), e4265786, 2023 | | 2023 |
| Targeting Autophagy to Overcome Resistance to Immunogenic Chemotherapy in High-Risk Multiple Myeloma A Gulla, E Morelli, MK Samur, M Johnstone, C Botta, D Vinaixa, M Turi, ... Blood 140 (Supplement 1), 7114-7115, 2022 | | 2022 |
